Literature DB >> 6338041

Regulation of human immunoglobulin E synthesis in acute graft versus host disease.

J A Saryan, J Rappeport, D Y Leung, R Parkman, R S Geha.   

Abstract

Immunoglobulin (Ig) E synthesis was studied in vitro in eight patients who had received transplants of allogeneic bone marrow. Seven of these patients developed acute graft vs. host disease (GVHD) and elevated serum IgE levels, whereas the eighth did not. In vitro synthesis of IgE, but not of IgG, was elevated in cultures of lymphocytes obtained during acute GVHD (17,923 +/- 14,607 pg/10(6) cells) but not in cultures of lymphocytes obtained after resolution of the acute GVHD when the serum IgE had returned to normal (106 +/- 31 pg/10(6) cells). In contrast, lymphocytes from the patient with no acute GVHD, like normal lymphocytes, failed to synthesize IgE in vitro. The increased in vitro IgE synthesis in acute GVHD was suppressed by normal allogeneic lymphocytes and by autologous lymphocytes obtained after the resolution of the acute GVHD, but not by allogeneic lymphocytes obtained from patients undergoing acute GVHD. The deficiency in functional IgE-specific suppressor cells in acute GVHD occurred in the face of normal or increased percentages of circulating T8+ cells, which in normal subjects contain the IgE-specific suppressor cells. In two patients studied, there was evidence of activated IgE-specific, circulating helper T cells. T cells from these two patients, but not normal T cells, secreted spontaneously upon culture in vitro a factor that induced IgE, but not IgG, synthesis by normal B cells. Finally, a survey of 21 bone marrow transplant recipients revealed that acute GVHD was a necessary requirement for the development of elevated serum IgE levels in recipients of bone marrow transplants. These results suggest that acute GVHD is accompanied by an imbalance in IgE-specific immunoregulatory T cells consisting of activated helper T cells and deficient suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338041      PMCID: PMC436903          DOI: 10.1172/jci110800

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Suppression of IgE antibody production in SJL mice. I. Nonspecific suppressor T cells.

Authors:  N Watanabe; S Kojima; Z Ovary
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

2.  Control of IgE antibody production by suppressor substances.

Authors:  D H Katz
Journal:  J Allergy Clin Immunol       Date:  1978-07       Impact factor: 10.793

Review 3.  Abnormalities in the regulation of human IgE synthesis.

Authors:  R H Buckley; W G Becker
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  Production of human immunoglobulin E antibody in vitro.

Authors:  A H Tjio; W M Hull; G J Gleich
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

5.  Human IgE biosynthesis in vitro: studies with atopic and normal blood mononuclear cells and subpopulations.

Authors:  P M Fiser; R H Buckley
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Regulation of antibody response in different immunoglobulin classes. I. Selective suppression of anti-DNP IgE antibody response by preadministration of DNP-coupled mycobacterium.

Authors:  T Kishimoto; Y Hirai; M Suemura; Y Yamamura
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

7.  Aberrations of suppressor T cells in human graft-versus-host disease.

Authors:  E L Reinherz; R Parkman; J Rappeport; F S Rosen; S F Schlossman
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

8.  Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.

Authors:  K Ishizaka; T Adachi
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

9.  Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity.

Authors:  N Chiorazzi; D A Fox; D H Katz
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy.

Authors:  C L Reinisch; S L Andrew; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  7 in total

Review 1.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 2.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

Review 3.  Control of IgE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

4.  Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4.

Authors:  J M Doutrelepont; M Moser; O Leo; D Abramowicz; M L Vanderhaegen; J Urbain; M Goldman
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

5.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Human rib bone marrow mononuclear cells spontaneously synthesize and secrete IgE in vitro.

Authors:  R P MacDermott; G A Jendrisak; G S Nash; S Schreiber; M J Bertovich; M Nahm; M Nonaka; P Fitzgerald; D H Katz; J F Marcelletti
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Induction of IgE synthesis in normal human B cells. Sequential requirements for activation by an alloreactive T cell clone and IgE-potentiating factors.

Authors:  D Y Leung; M C Young; N Wood; R S Geha
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.